Cai Bin, Li Sheng-de, Li Hang, Liu Zhen-Qian, Peng Bin
Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Cerebrovascular Diseases Hospital, Henan Provincial People's Hospital, Zhengzhou, China.
Front Neurol. 2020 Oct 8;11:545860. doi: 10.3389/fneur.2020.545860. eCollection 2020.
Many studies have suggested that the clinical features of male patients with ischemic stroke are different from those of female patients, but related data on Chinese patients are scarce. Therefore, this study aimed to identify the differences in treatment delays, complications related to intravenous thrombolysis, and prognosis between male and female patients with ischemic stroke in China. The data of patients with ischemic stroke who received intravenous thrombolysis were retrospectively analyzed. The data were obtained from the China Hospital Stroke Registry from January 2017 to April 2019. The general clinical characteristics, onset-to-door time, door-to-needle time, complications related to thrombolysis, National Institute of Health Stroke Scale (NIHSS) scores, and in-hospital mortality were compared between male and female patients to identify any sex differences in these factors. A multi-factorial analysis was conducted to explore whether sex is associated with in-hospital mortality and complications of intracerebral hemorrhage after thrombolysis. A total of 26,475 patients with ischemic stroke who received intravenous thrombolysis were involved in the study. The data were collected from 902 hospitals in 29 provinces, autonomous regions, and municipalities in China. The door-to-needle time was longer in female than in male patients (49 [35, 67] vs. 48 [35, 65], = 0.008). Furthermore, the frequencies of intracerebral hemorrhage (4.1 vs. 3.2%, < 0.001) and in-hospital mortality (2.55 vs. 1.83%, < 0.001) were higher in female vs. male patients. However, sex was not associated with intracerebral hemorrhage and in-hospital mortality according to the adjusted multi-factorial analysis. In addition, improvement in NIHSS scores was greater in female patients than in male patients [-3 (-6, -1) vs. -3 (-5, -1), = 0.036]. After adjusting for other predictors sex was not associated with intracerebral hemorrhage after thrombolysis or in-hospital mortality. Further study is warranted to evaluate the long-term outcomes in the different sexes.
许多研究表明,缺血性中风男性患者的临床特征与女性患者不同,但关于中国患者的相关数据却很匮乏。因此,本研究旨在明确中国缺血性中风男性和女性患者在治疗延迟、静脉溶栓相关并发症以及预后方面的差异。对接受静脉溶栓的缺血性中风患者的数据进行了回顾性分析。数据取自2017年1月至2019年4月的中国医院卒中登记系统。比较了男性和女性患者的一般临床特征、发病至入院时间、入院至溶栓时间、溶栓相关并发症、美国国立卫生研究院卒中量表(NIHSS)评分以及住院死亡率,以确定这些因素中是否存在性别差异。进行了多因素分析,以探讨性别是否与溶栓后脑出血的住院死亡率及并发症相关。共有26475例接受静脉溶栓的缺血性中风患者参与了本研究。数据收集自中国29个省、自治区和直辖市的902家医院。女性患者的入院至溶栓时间比男性患者长(49[35,67]对48[35,65],P = 0.008)。此外,女性患者的脑出血发生率(4.1%对3.2%,P < 0.001)和住院死亡率(2.55%对1.83%,P < 0.001)均高于男性患者。然而,根据校正后的多因素分析,性别与脑出血及住院死亡率无关。此外,女性患者的NIHSS评分改善幅度大于男性患者[-3(-6,-1)对-3(-5,-1),P = 0.036]。在校正其他预测因素后,性别与溶栓后脑出血或住院死亡率无关。有必要进一步研究以评估不同性别的长期预后。